Cullinan Oncology Funding: $499M Raised, IPO (2021)

Cullinan Oncology is based in Cambridge, Massachusetts. It has raised $499M in total funding. Latest round: IPO.

Cullinan Oncology funding overview

Cullinan Oncology is based in Cambridge, Massachusetts. Cullinan Oncology has raised $499M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in January 2021. The round record for Cullinan Oncology runs through 2021; nothing later has been disclosed. Investors on record include MPM Capital, Vida Ventures, F2 Ventures, UBS Oncology Impact Fund. 4 distinct backers are named across the disclosed rounds.

Cullinan Oncology at a glance

Total raised
$499M
Latest round
IPO
Latest round date
January 2021
Headquarters
Cambridge, Massachusetts
Notable investors
MPM Capital, Vida Ventures, F2 Ventures, UBS Oncology Impact Fund

Frequently asked about Cullinan Oncology funding

How much has Cullinan Oncology raised?
Cullinan Oncology has raised $499M in total disclosed funding across the rounds on record.
Who has invested in Cullinan Oncology?
MPM Capital, Vida Ventures, F2 Ventures, UBS Oncology Impact Fund are named among the investors backing Cullinan Oncology.
What was the latest Cullinan Oncology funding round?
The most recent disclosed round is an IPO, announced in January 2021.
Where is Cullinan Oncology based?
Cullinan Oncology is based in Cambridge, Massachusetts.
When did Cullinan Oncology last raise?
The last disclosed Cullinan Oncology round closed in January 2021 at IPO.

Every Cullinan Oncology figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Cambridge at a similar stage.

Companies related to Cullinan Oncology (35)

Browse related funding lists (7)

Company funding database · Investor directory · Founder database · Mega-rounds 2026